KURT VANDERVEEN: Open Payments
NPI 1407941396 · GRANDVILLE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,429 in 70 payments from 20 companies in 2025. Trend: 2023 $2,128 · 2024 $2,902 · 2025 $1,429
Food & beverage: $1,429
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $213 |
| GENZYME CORPORATION | 9 | $199 |
| Organon LLC | 15 | $183 |
| Arcutis Biotherapeutics, Inc. | 3 | $119 |
| Novartis Pharmaceuticals Corporation | 5 | $113 |
| Janssen Biotech, Inc. | 3 | $68 |
| UCB, Inc. | 3 | $59 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $56 |
| E.R. Squibb & Sons, L.L.C. | 3 | $53 |
| Amgen Inc. | 2 | $52 |
Products named: DUPIXENT, VTAMA, SKYRIZI, Zoryve, COSENTYX, TREMFYA, RINVOQ, Bimzelx.
Industry payments across MI — which companies pay providers there.
